Above you can see the medicines for the treatment of asthma marketed by Mundipharma in Denmark.

A good life with asthma

Asthma a persistent inflammatory illness of the lungs which is closely associated with heredity and factors in the surrounding environment, including allergens, irritants such as tobacco smoke, respiratory tract infections and physical exertion. Asthma affects people of all ages, but most frequently begins in childhood. In up to half of people with asthma, symptoms commence during childhood.1

The inflammatory state causes the respiratory tract muscles to contract while at the same time forming phlegm. Asthma patients find it difficult to catch their breath, they quickly get out of breath and they often have coughing fits along with wheezing. The symptoms are worsened by respiratory infections caused by viruses and bacteria.

Use of the right medicine allows the vast mamority of sufferers to live a completely normal life – despite of their asthma. Mundipharma endeavours to give doctors new possibilities to treat the disease and improve the quality of life for the 30 million Europeans that suffer the disease.2
 

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017

2. Braman, S. The Global Burden of Asthma. Chest 2006;130:4S-12S

 

This site is intended for Danish audiences only.

flutiform®

Obtain information about flutiform® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

Unixan®

Obtain information about Unixan® here:

Min medicin

Product leaflet

Product summary

 

This site is intended for Danish audiences only.

© 2018 Mundipharma A/S

Address

Mundipharma A/S
Frydenlundsvej 30, Building E,
2950 Vedbæk - Denmark

Contact

Phone: +45 45 17 48 00
Fax: +45 45 17 48 29
Monday - Friday at 9.00 - 16.00
mundipharma@mundipharma.dk

About Mundipharma

Mundipharma A/S is a part of Purdue/Mundipharma/Napp, which is an international network of independent associated medical companies.

Conditions for the use of Mundipharma.dk